LINC02091: A Drug Target / Disease Biomarker (G100506371)

Target Name: LINC02091

NCBI ID: G100506371

LINC02091

Other Name(s): long intergenic non-protein coding RNA 2091 | Long intergenic non-protein coding RNA 2091

LINC02091: A Drug Target / Disease Biomarker

LINC02091 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is long non-coding RNA gene LINC02091, and it is located on chromosome 6p21.3.

LINC02091 is a key regulator of gene expression in various organisms, including humans. It has been shown to play a role in the regulation of inflammation, immune response, and cell survival.

One of the most promising aspects of LINC02091 is its potential as a drug target. Its ability to regulate gene expression makes it an attractive target for small molecules that can modulate its activity. Additionally, its widespread expression in various tissues makes it an attractive candidate for diagnostic biomarkers.

Research has shown that LINC02091 is involved in the regulation of several important biological processes, including inflammation, stress, and cell survival. It has been shown to play a role in the regulation of inflammatory responses, and to contribute to the development of neurodegenerative diseases.

In addition to its potential as a drug target, LINC02091 is also a promising biomarker for a variety of diseases. Its widespread expression in various tissues makes it an attractive candidate for diagnostic tools, such as diagnostic scans or blood tests. Additionally, its regulation of gene expression makes it an attractive candidate for therapeutic targeting, either alone or in combination with other treatments.

The identification and characterization of LINC02091 as a potential drug target and biomarker is an important step in the development of new treatments for a variety of diseases. Further research is needed to fully understand its role and potential as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2091

The "LINC02091 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02091 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets